IL6 and acute coronary syndrome: The interleukin-6 (IL-6) signaling pathway is a crucial mediator of inflammation in the lesions (58), and elevated plasma IL-6 in patients with acute coronary syndrome is currently the most powerful predictor of increased mortality in both short and long terms (59, 60).